Aperture Tracker

Sectors › Healthcare & Life Sciences

Healthcare & Life Sciences funding

Healthcare & Life Sciences

New since yesterday No rounds announced on Sat Nov 14. Most recent: 1 round on Fri Nov 13.

AI for health care, biotech and drug discovery.

1,616 rounds, $46.1B raised by 1,345 companies, Jan 2, 2023 to Nov 14, 2026. Top three companies: Isomorphic Labs 6%, ŌURA 2%, Abridge 2%.

Companies by capital raised
CompanyHQCapital raisedRounds
Isomorphic LabsUnited Kingdom$2.7B2
ŌURAFinland$1.1B3
AbridgeUnited States$1B5
Neko HealthSweden$1B3
Xaira TherapeuticsUnited States$1B1
NeuralinkUnited States$973M3
SandboxAQUnited States$800M3
OpenEvidenceUnited States$735M4
EnvedaUnited States$697M6
Pathos AIUnited States$664M3
Mirador TherapeuticsUnited States$650M2
NewLimitUnited States$605M3
Chai DiscoveryUnited States$600M3
Colossal BiosciencesUnited States$470M3
Eikon TherapeuticsUnited States$457M2
Harbinger HealthUnited States$430M2
Judi HealthUnited States$417M3
Precision NeuroscienceUnited States$393M3
Hippocratic AIUnited States$387M5
Formation BioUnited States$372M1
TruvetaUnited States$320M1
Ambience HealthcareUnited States$313M2
VerilyUnited States$300M1
Function HealthUnited States$298M1
InnovaccerUnited States$275M1
The ten largest rounds
CompanyAmountStageAnnounced
Isomorphic Labs$2.1BSeries BMay 12, 2026
Xaira Therapeutics$1BUnlabeledApr 24, 2024
ŌURA$900MSeries EOct 14, 2025
Neko Health$700MSeries CJul 15, 2026
Neuralink$650MSeries EMay 27, 2025
Isomorphic Labs$600MUnlabeledMar 31, 2025
SandboxAQ$500MSeries DFeb 14, 2023
NewLimit$435MSeries CJun 2, 2026
Chai Discovery$400MSeries CJul 14, 2026
Mirador Therapeutics$400MSeries AMar 21, 2024